Hypercholesterolemia is a significant risk factor for AD and was proven to enhance the activity of the β-secretase pathway that processes amyloid precursor protein through the formation of lipid rafts, thereby promoting Aβ deposition, aggravating Aβ neurotoxicity, and subsequently leading to the occurrence of AD [26]. This evidence concerns the gene APP and Hypercholesterolemia.